<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药魔方Info | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-12T16:24:53+08:00</updated>
  <subtitle>传递医药信息，分享资源数据！充电5分钟，吹牛2小时！</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>正大天晴「泊马度胺胶囊」首仿获批！原研2020前3季度销售额超22亿美元</title>
    <updated>2020-11-12T16:09:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/nGz63ZIS2BmMo6gdwXJ2qg</id>
    <link href="https://mp.weixin.qq.com/s/nGz63ZIS2BmMo6gdwXJ2qg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>辉瑞CEO高位抛售60%个人股票</title>
    <updated>2020-11-12T16:09:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/q6zvNJHzLAB0oj6_Oi82MQ</id>
    <link href="https://mp.weixin.qq.com/s/q6zvNJHzLAB0oj6_Oi82MQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>豪森药业「注射用替加环素」首家通过一致性评价</title>
    <updated>2020-11-12T16:09:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/Y7dR6rk2pXbarMQkt3PArA</id>
    <link href="https://mp.weixin.qq.com/s/Y7dR6rk2pXbarMQkt3PArA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Keytrud在华第7项适应症拟优先审评：一线结直肠癌</title>
    <updated>2020-11-12T16:09:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/P-uzt9QGLFwQTVIl_Ds4EQ</id>
    <link href="https://mp.weixin.qq.com/s/P-uzt9QGLFwQTVIl_Ds4EQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国产第2家！青峰药业「富马酸丙酚替诺福韦片」获批上市</title>
    <updated>2020-11-12T16:09:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/APcczP5BG8dLmbWbpInFtw</id>
    <link href="https://mp.weixin.qq.com/s/APcczP5BG8dLmbWbpInFtw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>苑东生物2款仿制药获批！盐酸美金刚缓释胶囊为国内首家</title>
    <updated>2020-11-12T16:09:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/UllK9p-HDA7omz69M9dHuQ</id>
    <link href="https://mp.weixin.qq.com/s/UllK9p-HDA7omz69M9dHuQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>复星引进的新冠疫苗BNT162b2国内临床申请获受理</title>
    <updated>2020-11-12T16:09:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/d4ekuVdpR6JNLEXIgZaWvQ</id>
    <link href="https://mp.weixin.qq.com/s/d4ekuVdpR6JNLEXIgZaWvQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>BMS宣布发行70亿美元票据，用于收购MyoKardia</title>
    <updated>2020-11-12T16:09:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/-8bJP778qwGi-b42qVHuZw</id>
    <link href="https://mp.weixin.qq.com/s/-8bJP778qwGi-b42qVHuZw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>8家跨国药企2020前3季度中国业绩出炉！10余款新药已在中国提交上市申请</title>
    <updated>2020-11-11T17:00:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/vX-O6vf5nPthaIoNx2NWAw</id>
    <link href="https://mp.weixin.qq.com/s/vX-O6vf5nPthaIoNx2NWAw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>首个国产ALK抑制剂！贝达药业「恩沙替尼」即将获批</title>
    <updated>2020-11-11T17:00:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/hJ9R9R0X6ieSOOOVCpA_3w</id>
    <link href="https://mp.weixin.qq.com/s/hJ9R9R0X6ieSOOOVCpA_3w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>科伦药业「丙泊酚中/长链脂肪乳注射液」获批，第2家通过一致性评价</title>
    <updated>2020-11-11T17:00:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/5R-MJvL9Wlaig0ALPfxrRA</id>
    <link href="https://mp.weixin.qq.com/s/5R-MJvL9Wlaig0ALPfxrRA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FGFR2单抗胃癌II期研究成功，Five Prime股价暴涨350%</title>
    <updated>2020-11-11T17:00:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/pwYyCLwCv1pmJV2OhLdnig</id>
    <link href="https://mp.weixin.qq.com/s/pwYyCLwCv1pmJV2OhLdnig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>阿斯利康Calquence在欧盟获批治疗成人慢性淋巴细胞白血病</title>
    <updated>2020-11-11T17:00:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/VLuRcOaFrBXrKR4MnA8K6g</id>
    <link href="https://mp.weixin.qq.com/s/VLuRcOaFrBXrKR4MnA8K6g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>仑伐替尼+帕博利珠单抗一线治疗晚期肾细胞癌Ⅲ期研究获得积极结果</title>
    <updated>2020-11-11T17:00:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/W0bOA4b-iG1O0-y8hFt9Dw</id>
    <link href="https://mp.weixin.qq.com/s/W0bOA4b-iG1O0-y8hFt9Dw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>华东医药西格列汀二甲双胍片（I）即将获批</title>
    <updated>2020-11-10T17:48:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/neor19PFmRo8eVyn_E40bg</id>
    <link href="https://mp.weixin.qq.com/s/neor19PFmRo8eVyn_E40bg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>安进DLL3/CD3双特异性抗体首个概念性验证I期数据公布</title>
    <updated>2020-11-10T17:48:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/fF16FNBHMk91MaZCo5j5Fg</id>
    <link href="https://mp.weixin.qq.com/s/fF16FNBHMk91MaZCo5j5Fg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>229万美元首付款！恒瑞许可东亚公司PD-L1/TGF-β双抗韩国权益</title>
    <updated>2020-11-10T17:48:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/db9niQe7POUT4bgHa8jbUA</id>
    <link href="https://mp.weixin.qq.com/s/db9niQe7POUT4bgHa8jbUA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>赛伦生物科创板IPO获受理，独家抗蛇毒血清毛利率达90%</title>
    <updated>2020-11-10T17:48:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/eVHeIIV2pB0y2xnn8cjtDg</id>
    <link href="https://mp.weixin.qq.com/s/eVHeIIV2pB0y2xnn8cjtDg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>湖北药品带量采购：入围1-2家的品种进行谈判、议价</title>
    <updated>2020-11-10T17:48:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/kXWitkqWo80lAksr8P-igw</id>
    <link href="https://mp.weixin.qq.com/s/kXWitkqWo80lAksr8P-igw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>远大医药Tavo治疗耐药转移性黑色素瘤注册性临床试验中期数据远超主要终点</title>
    <updated>2020-11-10T17:48:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/VMHlaNI4j5v25RyF9iFD-Q</id>
    <link href="https://mp.weixin.qq.com/s/VMHlaNI4j5v25RyF9iFD-Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>